Indications
| Mesh Heading | Maximum Phase | Reference | |
|---|---|---|---|
| Obesity | Phase 1 | ClinicalTrials | |
| Lipodystrophy | Phase 2 | ClinicalTrials | |
| Body Weight | Phase 2 | ClinicalTrials | |
| Diabetes Mellitus; Diabetes Mellitus, Type 1 | Phase 1 | ClinicalTrials | |
| Obesity | Phase 2 | ClinicalTrials | |
| Lipodystrophy; Metabolic Syndrome | Phase 2 | ClinicalTrials | |
| Overweight | Phase 1/Phase 2 | ClinicalTrials | |
| Insulin Resistance; Lipodystrophy; Lipodystrophy, Congenital Generalized | Phase 2/Phase 3 | ClinicalTrials | |
| Obesity | Phase 3 | ClinicalTrials |
CONTENTS